Zoetis Declares Second Quarter 2024 Dividend

Rhea-AI Summary

Zoetis Inc. (ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024, payable on June 4, 2024, to all holders of record of the Company’s common stock as of April 19, 2024.

Positive

• Zoetis Inc. (ZTS) has declared a dividend for the second quarter of 2024.
• The dividend amount is $0.432 per share.
• The dividend will be paid on June 4, 2024.
• The record date for the dividend is April 19, 2024.

Negative

• None.

Financial Analyst

The announcement of a dividend declaration by Zoetis Inc. is a significant signal to the market, reflecting the company's current financial health and its management's confidence in its ability to generate steady cash flows. From a financial analyst's perspective, the key aspects to consider are the dividend yield, the payout ratio and the company's historical dividend growth. Investors often view consistent and growing dividends as an indicator of a company's stability and maturity, as well as a sign of its commitment to returning value to shareholders.

It is also important to assess the dividend in the context of the company's overall financial strategy, including its investment in growth opportunities, debt management and cash reserves. A sustainable dividend policy should strike a balance between rewarding shareholders and maintaining sufficient capital to fund future growth and navigate economic fluctuations. In the case of Zoetis Inc., stakeholders would benefit from understanding how this dividend payment compares to previous ones and how it aligns with the company's long-term financial planning.

Market Research Analyst

Examining the impact of Zoetis Inc.'s dividend on the broader market requires an understanding of its position within the pharmaceuticals and animal health industry. As a market research analyst, one would evaluate the company's market share, competitive landscape and growth prospects. The declaration of a dividend might influence investor sentiment and could potentially affect the stock's attractiveness, particularly among income-focused investors.

Furthermore, analyzing industry trends, such as spending on pet health and livestock products, can provide context for the company's performance. For instance, an increase in pet ownership or livestock production could signal a favorable market environment for Zoetis, supporting its ability to maintain or increase dividend payments. Conversely, industry headwinds could put pressure on the company's profitability and, by extension, its dividend sustainability.

Economist

From an economic standpoint, dividend payments can be indicative of broader economic conditions. An economist would explore how macroeconomic factors, such as interest rates, inflation and economic growth, influence corporate profitability and dividend policies. In a low-interest-rate environment, for example, dividends become more attractive as they may offer higher yields than fixed-income securities.

Additionally, the timing of the dividend payout and its correlation with economic cycles can provide insights into the company's strategic financial decisions. If the economy is in a downturn, a company maintaining or increasing its dividend might be seen as a robust move, showcasing resilience. On the other hand, during economic expansions, companies might be expected to invest more heavily in growth opportunities rather than paying out dividends. Zoetis Inc.'s dividend declaration could thus be interpreted within the context of current economic conditions and forecasts.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024. The dividend will be paid on Tuesday, June 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, April 19, 2024.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.

DISCLOSURE NOTICES

Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.

ZTS-COR
ZTS-IR
ZTS-FIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20240206926901/en/

Media Contacts:

Jenielle Alonso

1-973-945-4333 (o)

jenielle.alonso@zoetis.com



Laura Panza

1-973-975-5176 (o)

laura.panza@zoetis.com



Investor Contacts:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com



Nick Soonthornchai

1-973-443-2792 (o)

nick.soonthornchai@zoetis.com

Source: Zoetis Inc.

What is the dividend amount declared by Zoetis Inc. for the second quarter of 2024?

Zoetis Inc. (ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024.

When will the dividend be paid to the shareholders?

The dividend will be paid on Tuesday, June 4, 2024.

Who is eligible to receive the dividend?

The dividend will be paid to all holders of record of Zoetis Inc.'s common stock as of the close of business on Friday, April 19, 2024.